Key Record Dates
ClinicalTrials.gov Identifier: | NCT04389840 |
---|---|
Brief Title: | Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure |
First Submitted : | May 13, 2020 |
First Submitted that Met QC Criteria : | May 13, 2020 |
First Posted : | May 15, 2020 |
Results First Submitted : | May 27, 2022 |
Results First Posted with QC Comments : | June 23, 2022 |
Results First Submitted that Met QC Criteria : | August 8, 2022 |
Results First Posted : | August 30, 2022 |
Last Update Submitted that Met QC Criteria : | August 8, 2022 |
Last Update Posted : | August 30, 2022 |